Renal Cell Carcinoma

RENAL CELL CARCINOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Many Immune Checkpoint Inhibitor Combination Therapies Show No Evidence of Drug Synergy

The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?

Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.

RENAL CELL CARCINOMA NEWS

HRQOL Data Support First-Line Lenvatinib-Pembrolizumab in Advanced Renal Cell Carcinoma

May 12, 2022

DNA

DNA Assay May Distinguish Responses to mRCC Immunotherapy

April 29, 2022

intravenous iv drip

Efficacy, Safety of Triple Combo for Advanced Kidney Cancer Probed

April 29, 2022

Surgeon surrounded by images of people

Treatment Advances Have Upped Survival in Metastatic Kidney Cancer

April 28, 2022

Patient getting vaccinated.

COVID-19 mRNA Vaccine Efficacy Wanes Over Time in RCC Cases

April 27, 2022

Next post in Renal Cell Carcinoma

Surgeon surrounded by images of people

Treatment Advances Have Upped Survival in Metastatic Kidney Cancer